Maximizing PTH Anabolic Osteoporosis Therapy
Abstract
The purpose of this study is to test the efficacy of parathyroid hormone (PTH) mono-therapy and PTH anti-catabolic combination therapies on Nmp4-/-and wild type (WT) mice. The scope of the research comprises the following specific aims: (i and ii) to determine the impact of Nmp4 on the efficacy of PTH mono- and combination therapies with various anti-catabolics in ovariectomized (ovx) mice; (iii) to determine the cell type-specific contributions to the enhanced response of the Nmp4-/- mouse to osteoporosis therapies.
Document Details
- Document Type
- Technical Report
- Publication Date
- Nov 01, 2017
- Accession Number
- AD1054780
Entities
People
- Joseph Bidwell